CRBU Insider Trading Activity and SEC Form 4 Filings
CRBU insider trading summary
Over the past 12 months, insiders at Caribou Biosciences, Inc. (CRBU) reported 4 sales worth $35K by 4 insiders and no open-market purchases on SEC Form 4. Net insider selling was $35K.
Latest CRBU insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Feb 24, 2026 | Tina M. Albertson | Chief Medical Officer | Sell | $2K (1,066 @ $1.96) |
| Feb 24, 2026 | Ruhi Ahmad Khan | Chief Business Officer | Sell | $14K (6,938 @ $1.96) |
| Feb 24, 2026 | Timothy P Kelly | Chief Technology Officer | Sell | $6K (3,147 @ $1.96) |
| Feb 24, 2026 | Barbara G McClung | Chief Legal Officer | Sell | $14K (6,938 @ $1.96) |
| Mar 14, 2025 | Rachel E. Haurwitz | President and CEO | Buy | $20K (20,000 @ $1.02) |
| Feb 21, 2025 | Ruhi Ahmad Khan | Chief Business Officer | Sell | $5K (3,564 @ $1.35) |
| Feb 21, 2025 | Barbara G McClung | Chief Legal Officer | Sell | $5K (3,564 @ $1.35) |
| Feb 21, 2025 | Steven Kanner | Chief Scientific Officer | Sell | $5K (3,564 @ $1.35) |
| Jan 29, 2025 | Sriram Ryali | Chief Financial Officer | Buy | $25K (17,360 @ $1.42) |
| Jan 19, 2023 | Syed Ali-aamir Rizvi | Chief Medical Officer | Sell | $36K (5,627 @ $6.31) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.